Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?

E-ISSN： 1875-6204|5|2|87-101

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.2, 2007-06, pp. : 87-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concordance of pharmacogenetic markers in germline and colorectal tumor DNA

By Marsh Sharon Mallon Mary Ann Goodfellow Paul McLeod Howard L

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 873-877

Future Medicine

Access to resources Recommend Favorite

DNA amplification techniques in pharmacogenomics

By Morlighem Jean-ÉÉtienne Harbers Matthias Traeger-Synodinos Jan Lezhava Alexander

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 845-860

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

By García-Campelo Rosario Alonso-Curbera Guillermo Antón Aparicio LM Rosell Rafael

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2015-2026

Informa Healthcare

Access to resources Recommend Favorite

Cancer Pharmacogenomics: DNA Genotyping and Gene Expression Profiling to Identify Molecular Determinants of Chemosensitivity

By Auman J. Todd McLeod Howard

Drug Metabolism Reviews, Vol. 40, Iss. 2, 2008-04 ,pp. : 303-315

Informa Healthcare

Access to resources Recommend Favorite

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

By Lesko Lawrence J Zineh Issam

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 507-512

Future Medicine

Access to resources Recommend Favorite